Cutler Group LP Catalyst Biosciences, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$4.52 - $7.91 $10,034 - $17,560	-2,220 Reduced 28.76%	5,500 $37,000
Q2 2019 Aug 09, 2019	BUY	$7.08 - $10.6 $48,993 - $73,352	6,920 Added 865.0%	7,720 $56,000
Q4 2018 Feb 05, 2019	SELL	$6.59 - $11.28 $186,497 - $319,224	-28,300 Reduced 97.25%	800 $6,000
Q3 2018 Nov 07, 2018	BUY	$9.35 - $12.44 $187,935 - $250,044	20,100 Added 223.33%	29,100 $313,000
Q2 2018 Aug 10, 2018	BUY	$9.11 - $28.88 $71,058 - $225,264	7,800 Added 650.0%	9,000 $105,000
Q1 2018 May 11, 2018	BUY	$14.18 - $35.6 $17,016 - $42,720	1,200 New	1,200 $30,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.